IL191586A0 - Heterocycle-substituted 3-alkyl azetidine derivatives - Google Patents

Heterocycle-substituted 3-alkyl azetidine derivatives

Info

Publication number: IL191586A0
Authority: IL; Israel
Prior art keywords: heterocycle; substituted; azetidine derivatives; alkyl; alkyl azetidine
Prior art date: 2005-11-28

Application number

IL191586A

Original Assignee

Merck Sharp & Dohme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-28

Filing date

2008-05-20

Publication date

2008-12-29

2008-05-20 Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme

2008-12-29 Publication of IL191586A0 publication Critical patent/IL191586A0/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Addiction (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Child & Adolescent Psychology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL191586A 2005-11-28 2008-05-20 Heterocycle-substituted 3-alkyl azetidine derivatives IL191586A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US74018305P	2005-11-28	2005-11-28
PCT/US2006/045328 WO2007062193A1 (en)	2005-11-28	2006-11-22	Heterocycle-substituted 3-alkyl azetidine derivatives

Publications (1)

Publication Number	Publication Date
IL191586A0 true IL191586A0 (en)	2008-12-29

Family

ID=37779312

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL191586A IL191586A0 (en)	2005-11-28	2008-05-20	Heterocycle-substituted 3-alkyl azetidine derivatives

Country Status (15)

Country	Link
EP (1)	EP1954692A1 (en)
KR (1)	KR20080073721A (en)
AR (1)	AR058199A1 (en)
BR (1)	BRPI0619018A2 (en)
CR (1)	CR10014A (en)
DO (1)	DOP2006000261A (en)
EC (1)	ECSP088477A (en)
IL (1)	IL191586A0 (en)
MA (1)	MA30086B1 (en)
NO (1)	NO20082919L (en)
PE (1)	PE20070647A1 (en)
RU (1)	RU2008126248A (en)
SV (1)	SV2009002917A (en)
TW (1)	TW200804317A (en)
WO (1)	WO2007062193A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7906652B2 (en)	2005-11-28	2011-03-15	Merck Sharp & Dohme Corp.	Heterocycle-substituted 3-alkyl azetidine derivatives
EP2025674A1 (en)	2007-08-15	2009-02-18	sanofi-aventis	Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
US20100292282A1 (en) *	2007-10-24	2010-11-18	Campos Kevin R	Synthesis and crystalline forms of cb-1 antagonist/inverse agonist
US9440948B2 (en)	2010-09-03	2016-09-13	University Of Florida Research Foundation, Inc.	Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
WO2012120055A1 (en)	2011-03-08	2012-09-13	Sanofi	Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120052A1 (en)	2011-03-08	2012-09-13	Sanofi	Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
EP2683700B1 (en)	2011-03-08	2015-02-18	Sanofi	Tetra-substituted oxathiazine derivatives, method for their preparation, their usage as medicament and medicament containing same and its use
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8828995B2 (en)	2011-03-08	2014-09-09	Sanofi	Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2805810B1 (en) *	2000-03-03	2002-04-26	Aventis Pharma Sa	PHARMACEUTICAL COMPOSITIONS CONTAINING 3- AMINO-AZETIDINE DERIVATIVES, THE NEW DERIVATIVES AND THEIR PREPARATION
FR2805817B1 (en) *	2000-03-03	2002-04-26	Aventis Pharma Sa	PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND THEIR PREPARATION
FR2805818B1 (en) *	2000-03-03	2002-04-26	Aventis Pharma Sa	AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP3939744B2 (en) *	2003-06-11	2007-07-04	メルクエンドカムパニーインコーポレーテッド	Substituted 3-alkyl and 3-alkenyl azetidine derivatives
CN101426500A (en) *	2005-05-02	2009-05-06	默克公司	Combination of dipeptidyl peptidase-iv inhibitor and a cannabinoid cb1 receptor antagonist for the treatment of diabetes and obesity

2006
- 2006-11-20 AR ARP060105076A patent/AR058199A1/en unknown
- 2006-11-22 RU RU2008126248/04A patent/RU2008126248A/en not_active Application Discontinuation
- 2006-11-22 BR BRPI0619018A patent/BRPI0619018A2/en not_active IP Right Cessation
- 2006-11-22 KR KR1020087012880A patent/KR20080073721A/en not_active Withdrawn
- 2006-11-22 EP EP06838347A patent/EP1954692A1/en not_active Withdrawn
- 2006-11-22 TW TW095143274A patent/TW200804317A/en unknown
- 2006-11-22 WO PCT/US2006/045328 patent/WO2007062193A1/en not_active Ceased
- 2006-11-23 DO DO2006000261A patent/DOP2006000261A/en unknown
- 2006-11-23 PE PE2006001495A patent/PE20070647A1/en not_active Application Discontinuation
2008
- 2008-05-20 IL IL191586A patent/IL191586A0/en unknown
- 2008-05-22 CR CR10014A patent/CR10014A/en not_active Application Discontinuation
- 2008-05-27 EC EC2008008477A patent/ECSP088477A/en unknown
- 2008-05-28 SV SV2008002917A patent/SV2009002917A/en not_active Application Discontinuation
- 2008-06-25 MA MA31075A patent/MA30086B1/en unknown
- 2008-06-27 NO NO20082919A patent/NO20082919L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
SV2009002917A (en)	2009-02-19
CR10014A (en)	2008-07-29
EP1954692A1 (en)	2008-08-13
KR20080073721A (en)	2008-08-11
ECSP088477A (en)	2008-06-30
DOP2006000261A (en)	2007-07-15
PE20070647A1 (en)	2007-08-11
RU2008126248A (en)	2010-01-10
WO2007062193A1 (en)	2007-05-31
MA30086B1 (en)	2008-12-01
BRPI0619018A2 (en)	2016-11-29
NO20082919L (en)	2008-08-27
AR058199A1 (en)	2008-01-23
TW200804317A (en)	2008-01-16

Publication	Publication Date	Title
GB0505941D0 (en)	2005-04-27	Human-to-mobile interfaces
EP1878727A4 (en)	2013-11-13	2-aminoquinazoline derivatives
ZA200707358B (en)	2009-08-26	1-benzylindole-2-carboxamide derivatives
IL192092A0 (en)	2008-12-29	Aryl-isoxazolo-4-yl-oxadiazole derivatives
HUS2000022I1 (en)	2020-07-28	Tiglien-3-one derivatives
ZA200802421B (en)	2009-01-28	1-Acyldihydropyrazol derivatives
IL192286A0 (en)	2008-12-29	Triazole derivatives
IL191586A0 (en)	2008-12-29	Heterocycle-substituted 3-alkyl azetidine derivatives
ZA200804257B (en)	2009-04-29	Azaindole-2-carboxamide derivatives
IL184841A0 (en)	2007-12-03	Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives
IL192235A0 (en)	2009-02-11	Aryl-isoxazol-4-yl-imidazole derivatives
PL1954674T3 (en)	2016-09-30	New n-phenethylcarboxamide derivatives
IL191138A0 (en)	2008-12-29	Pyrazoloisoquinoline derivatives
IL184559A0 (en)	2007-10-31	Imidazole derivatives
EP1870412A4 (en)	2009-12-30	2-thioethenyl carbapenem derivative
GB0511410D0 (en)	2005-07-13	Benzotrizepinone derivatives
ZA200706577B (en)	2010-02-24	Dihydroimidazothiazole derivatives
AU2005100526A4 (en)	2005-08-11	Windows Hydrogenerator
GB2424924B (en)	2009-09-16	Hinges
AU2005902963A0 (en)	2005-06-23	Auger
AU2005902628A0 (en)	2005-06-02	Auger
HK1124592A (en)	2009-07-17	Pyrazoloisoquinoline derivatives
HK1110595A (en)	2008-07-18	Dihydroimidazothiazole derivatives
AU2005907278A0 (en)	2006-01-19	Tiglien-3-one derivatives
AU2005906410A0 (en)	2005-12-01	QWIC bar